Atlas Trials

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

Clinical trial NCT01073553 · COMPLETED

Trial details

NCT number
NCT01073553
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anti-Infective Agents
Start date
2009-10-01
Primary completion
2009-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.